recombinant human endostatin Solution for injection 15 mg/3 ml
Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #39090
Clinical-stage pharmaceutical company focused on oncology, neuroscience, and autoimmune diseases. Develops innovative and generic medicines with growing global ambitions. Strategy includes partnerships and selective international expansion.